ArticleMolecular diversity2023

Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation.

Ravi S Manhas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.